When it Comes to CBD, the FDA Wants to See the Receipts
When it comes to cannabidiol (CBD), the U.S. Food and Drug Administration (FDA) isn’t quite ready to take a hit.
On Friday, May 31, 2019, the agency held its first hearing on CBD in Silver Spring, Maryland. More than 100 people testified, reports CNBC, many of whom extolled the virtues of CBD and its benefits—and implored the agency to set up a regulatory framework to legally add CBD to food products and dietary supplements.
Read more at Skin Inc. >>
